TD Cowen raised the firm’s price target on Ardelyx (ARDX) to $13 from $10 and keeps a Buy rating on the shares. The firm updated its model ahead of Q4 results.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARDX:
- Ardelyx: Commercial Momentum, Expanded Ibsrela Opportunity, and Strengthened IP Underpin Buy Rating
- Ardelyx announces first patient dosed in ACCEL
- 3 Best Stocks to Buy Today, 1/27/2026, According to Top Analysts
- Ardelyx price target raised to $15 from $8 at Jefferies
- Ardelyx price target raised to $14 from $11 at Citi